In the BioHarmony Drug Report Database

"Preview" Icon

Dirithromycin

Dynabac (dirithromycin) is a small molecule pharmaceutical. Dirithromycin was first approved as Dynabac on 1995-06-19. It is used to treat bacterial pneumonia, bronchitis, community-acquired infections, haemophilus infections, and staphylococcal infections amongst others in the USA.

 

Trade Name

 

Dynabac
 

Common Name

 

dirithromycin
 

ChEMBL ID

 

CHEMBL1237072
 

Indication

 

bacterial pneumonia, bronchitis, community-acquired infections, haemophilus infections, staphylococcal infections, streptococcal infections, tonsillitis
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Dirithromycin structure rendering